Mar­kets buzz as an­oth­er mR­NA biotech uni­corn looks to car­ry home a record $800M IPO haul

That oth­er mes­sen­ger RNA biotech uni­corn is look­ing to jump in­to Wall Street with an IPO that may seek a record $800 mil­lion and a val­u­a­tion of some $4 bil­lion.

Bankers are buzzing that Bank of Amer­i­ca and JP Mor­gan have al­ready been tapped for the IPO on be­half of BioN­Tech, a Ger­man biotech that has at­tract­ed con­sid­er­able at­ten­tion for its role as a leader in the mR­NA field, ac­cord­ing to a re­port in Reuters.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.